drugset / Trial / NCT03527316

Effect of Methylenedioxymethamphetamine (MDMA) (Serotonin Release) on Fear Extinction

NCT03527316 ↗

Phase 0 Completed 30 enrolled University Hospital, Basel, Switzerland
RandomizedCrossoverQuadruple-blindBasic science

Summary

Serotonin and oxytocin play a role in fear conditioning and fear extinction learning, psychological processes that are critically involved in psychiatric disorders such as posttraumatic stress disorder (PTSD). Specifically, administration of oxytocin has been shown to facilitate fear extinction in humans. Similarly, substances that release serotonin and oxytocin such as MDMA have been shown to enhance the extinction of fear memory in animals. However, there are no data on the effects of MDMA on fear extinction in humans. Therefore, the primary aim of this study is to investigate the role of acute serotonin release in the effects of fear extinction. MDMA will be used as pharmacological tool to induce serotonin release in this study.

Timeline

Start
2019-10-18
Primary completion
2020-12-10
Completion
2020-12-24

Drugs

EvaluationDrugModalityDoseRoute
Subject MDMA Unknown 125 mg —

Indications

No indication recorded.